Sage Journals: Discover world-class research

Free access

Research article

First published 2015-2

EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells

HI Onen, A Yilmaz, E Alp [...]

Human & Experimental Toxicology

Open access

Article commentary

First published 2019-04-02

Is rapamycin a rapalog?

David J. Glass, Dudley W. Lamming

Nutrition and Healthy Aging

Open access

Research article

First published 2017

Single Arm Phase I/II Study of Everolimus and Intravesical Gemcitabine in Patients with Primary or Secondary Carcinoma In Situ of the Bladder who failed Bacillus Calmette Guerin (NCT01259063)

Guido Dalbagni, Nicole Benfante, Daniel D. Sjoberg [...]

Bladder Cancer

Free access

Other

First published 2008-11

“TOR” rents of Excitement over Rapamycin's Antiepileptogenic Potential

Lisa R. Merlin

Epilepsy Currents

Retricted access

Research article

First published 2005-12

Late Expression of Nitroreductase in an Oncolytic Adenovirus Sensitizes Colon Cancer Cells to the Prodrug CB1954

Alexander N. Lukashev, Christophe Fuerer, Ming-Jen Chen [...]

Human Gene Therapy

Open access

Research article

First published 2016

Assessing Metabolic Changes in Response to mTOR Inhibition in a Mantle Cell Lymphoma Xenograft Model Using AcidoCEST MRI

Paul J. Akhenblit, Neale T. Hanke, Alexander Gill [...]

Molecular Imaging

Retricted access

Other

First published 2011-9

Acute cholecystitis in a patient with metastatic renal cell carcinoma treated with everolimus

Bulent Cetin, Ugur Coskun, Ramazan Yildiz [...]

Journal of Oncology Pharmacy Practice

Free access

Research article

First published 2013-9

Everolimus in the treatment of patients with advanced pancreatic neuroendocrine tumors: latest findings and interpretations

Eric Liu, Paula Marincola, Kjell Öberg

Therapeutic Advances in Gastroenterology

Retricted access

Research article

First published 2011-1

Everolimus: A New Mammalian Target of Rapamycin Inhibitor for the Treatment of Advanced Renal Cell Carcinoma

Tatjana Grgic, Lydia Mis, Julia M Hammond

Annals of Pharmacotherapy

Retricted access

Research article

First published 2012-9

Oncology;Everolimus: A New Treatment Option for Advanced Pancreatic Neuroendocrine Tumors

Lisa A Thompson, Miryoung Kim, Sarah D Wenger [...]

Annals of Pharmacotherapy

Search results